Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LI 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover efficient, cost-effective synthesis of 2-trifluoromethyl quinazolinone for drug development. Reduce production costs and supply chain risks with scalable multi-component one-pot method.
Reduce production costs and metal residues with this efficient photocatalytic route for high-purity o-amino aromatic ketones in drug development.
Discover a novel copper-catalyzed route for multifunctional indolizine derivatives with 72-82% yields. Reduce production costs and ensure supply chain stability for pharmaceutical applications.
Solve supply chain risks for 2,3-dihydroquinolone intermediates with this palladium-catalyzed method. Cheap raw materials, broad functional group tolerance, and simple post-treatment ensure stable production for your drug development.
Solve low-yield chromone synthesis challenges with palladium-catalyzed multi-component method. Get 99%+ purity, 85-92% yield, and cost-efficient production for pharma intermediates.
Solve C-S bond formation challenges with air-stable indole phosphine ligands. Achieve 90% yield at 0.5 mol% Pd loading. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve supply chain risks with this Pd-catalyzed quinolinone synthesis. 99%+ purity, 24-48h reaction time, and cheap raw materials. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve low-yield benzoindolizine synthesis with metal-free [3+2] cycloaddition. Achieve 85%+ yields, eliminate transition metal risks, and scale to 100 MT/yr. Contact for COA/MSDS.
Solve biliverdin production challenges: 73% yield, no column chromatography, 100-160°C scalable process. Reduce costs & supply risks for pharma R&D and procurement.
Solve fluorination challenges in drug development with this cost-effective, high-yield method. Ensure supply chain stability for active screening.
Solve multi-step synthesis challenges with 99.8% yield, 98.1% purity, and no hazardous gas emissions. Reduce production costs and environmental risks for cosmetic and pharmaceutical applications.
Solve chiral purity challenges in halichondrin synthesis with 99.7% ee and 92% yield. Reduce impurity removal burden for Eribulin mesylate production. CDMO expertise for scalable manufacturing.
Replace expensive gold/silver catalysts with zinc for 2,3,4-trisubstituted quinoline synthesis. Achieve 60%+ yields, 10,000x cost reduction, and scalable production for drug development.
Discover efficient, cost-effective synthesis of indolo[2,1a]isoquinoline compounds via palladium-catalyzed carbonylation. Ideal for drug development with high yield and broad substrate tolerance.
Overcome low yield & complex steps in flibanserin production. New 5-step route with 94.2% intermediate yield and 56.2% final yield. Reduce costs and supply chain risks.
Solve heavy metal contamination in 2-trifluoromethyl quinoline synthesis. Our metal-free, air-stable process cuts costs & ensures GMP compliance for drug development.
Discover scalable chiral indolinopyrrole synthesis with 99% ee and 90%+ yield. Ideal for oncology drug development. Reduce costs and supply chain risks.
Eliminate CO gas handling risks and reduce production costs with this scalable multi-component synthesis for high-purity pharmaceutical intermediates.
Discover how iodine-catalyzed metal-free synthesis of 3-arylthioimidazo[1,5-a]N-heterocycles solves transition metal contamination risks and improves yield for pharmaceutical intermediates.
Solve supply chain risks with this cost-effective, scalable trifluoromethyl chromonoquinoline synthesis. 99% purity, 100kgs-100MT production capacity. Contact for COA/MSDS.